Researchers at the University of Michigan Rogel Cancer Center have developed a 15-gene signature that helps classify clear cell kidney cancer patients...

Researchers have identified a biomarker that can help determine which medlinkrenal cancer/medlink patients are at a higher risk of recurrence. The

The gene signature for renal cancer can help clinicians identify recurrence risk earlier and potentially guide patient treatment strategies.

Researchers have discovered metabolic markers that forecast cancer patients' immunotherapy responses and survival outcomes, highlighting the...

Researchers have identified a Vascular Endothelial Growth Factor Receptor (VEGFR) that could lead to new treatments for colon and renal cancers. ...

MONDAY, July 1, 2024 -- Among patients with incompletely excised basal cell carcinoma (BCC), only about 16 percent with positive histopathologic...

A discovery by researchers at the University of British Columbia, Canada, promises to improve care for patients with endometrial cancer, the most...

Swedish researchers have surveyed all people under the age of 25 who have had cancer since 1958. The study, led by researchers at Linköping...

Researchers at the University of Turku in Finland have found a new function for an existing protein. They discovered that TIMP-1, a protein...

Treatment of gastrointestinal (GI) cancers is catching up with other areas of oncology and offering patients better prospects for survival and quality...